A new monoterpenoid indole alkaloid, ochroborbone (1), along with five known alkaloids (2-6), were isolated from the stems and leaves of Ochrosia borbonica. Among them, ochroborbone (1) is a rare C17-nor monoterpenoid indole alkaloid, and the known compounds (2-6) were isolated from Ochrosia for the first time. These structures were established on the basis of extensive spectroscopic methods. All isolated compounds were evaluated for their cytotoxicities against five human cancer cell lines: HL-60, SMMC-7721, A-549, MCF-7 and SW480 in vitro. Compounds 1 and 2 exhibited inhibitory effects with IC 50 values comparable with those of cisplatin.
The genus Ochrosia (Apocynaceae) is comprised of about 39 species that are distributed in tropical or subtropical Malaysia, Singapore, Indonesia, Viet Nam, Sri Lanka and Madagascar. Among the plants of this genus, three species were introduced and cultivated in Guangdong, Hainan and Taiwan Provinces in China. Ochrosia species were widely used as folk medicines for their antitumor activity [1] . Phytochemical studies on this genus have led to the isolation of various skeletal types of monoterpenoid indole alkaloids with antitumor activities, which have attracted pharmacologists' attention [2] [3] [4] [5] . As a part of our ongoing research into structurally and biologically interesting alkaloids from tropical medicinal plants in China, a chemical investigation of O. borbonica was thus undertaken and led to the isolation and characterization of a new monoterpenoid indole alkaloid, ochroborbone (1), together with five known alkaloids, naucleamide A (2) [6] , corynantheol (3) [7] , sitsirikine (4) [8] , 19, 20-dihydroisositsirikine (5) [9] , and 10hydroxy-19, 20-dihydroisositsirikine (6) [10] . Among them, ochroborbone (1) is a rare C17-nor monoterpenoid indole alkaloid, and the known compounds (2-6) were isolated from Ochrosia for the first time. Their structures with the relative configurations were elucidated on the basis of extensive spectroscopic methods. In addition, all isolated compounds were evaluated for their cytotoxicity against five human cancer cell lines in vitro. Herein, we describe the isolation, structure elucidation, and cytotoxic properties of these compounds.
Ochroborbone (1) was obtained as yellowish amorphous powder with a specific rotation of -82.6 (c 0.12, CH 3 OH). Its molecular formula, C 19 H 22 N 2 O 2 , was established by HRESIMS (m/z 311.1768 [M + H]  , calcd 311.1760). Its IR spectrum showed the presence of a hydroxyl group (3426 cm -1 ), an amide carbonyl group (1618 cm -1 ) and a phenyl group (1593 and 1452 cm -1 ). The UV absorption bands at 228 and 283 nm were characteristic of an indole alkaloid. The 13 C NMR and DEPT data revealed the presence of 19 carbon atoms, including 11 sp 2 carbon atoms, two sp 3 methines, five sp 3 methylenes and one methyl group. The 11 sp 2 carbon atoms were attributable to one indole ring group, one trisubstituted double bond, and one amide carbonyl group. The above data revealed that the structure of 1 was similar to that of naucleamide A (2) [6] . The only significant difference was the presence of one methylene carbon signal at δ 36.6 instead of one methine carbon at δ 48.8 and one methylene carbon signal at δ 62.9 in naucleamide A (2) [6] . Detailed analysis of spectroscopic data revealed that the hydroxymethyl at C-16 in naucleamide A (2) was replaced by a Figure 2 .
The observation of a strong cross-peak in the ROESY spectrum between H-15 and H-18 permitted the assignment of orientation of the olefinic bond between C-19 and C-20 as E. The relative configurations of 1 were assigned on the basis of the ROESY correlations ( Figure 2 All isolated compounds were evaluated for their cytotoxicity against five human cancer cell lines, HL-60, SMMC-7721, A-549, MCF-7, and SW480 by the MTT method. Compound 1 showed significant cell growth inhibitory activity against all cell lines with IC 50 values of 1.08 ± 0.06, 5.29 ± 0.11, 6.83 ± 0.12, 5.49 ± 0.08, and 8.94 ± 0.13 μM, respectively. Compound 2 showed moderate cell growth inhibitory activities against all cell lines with IC 50 values of 2.05 ± 0.15, 9.33 ± 0.16, 16.1 ± 0.15, 2.12 ± 0.08, and 28.6 ± 0.18 μM, respectively. The other compounds were inactive (IC 50 values of > 40 μM). The positive control, cisplatin, showed cytotoxicities with IC 50 values of 1.29 ± 0.12, 14.8 ± 0.18, 15.2 ± 0.2, 26.7 ± 0.09, and 28.3 ± 0.19 μM, respectively. It is noteworthy that alkaloids 1 and 2 exhibited significant inhibitory effects against five human cancer cell lines with IC 50 values similar to or even stronger than those of cisplatin.
A new monoterpenoid indole alkaloid, ochroborbone (1), together with five known alkaloids (2-6), were isolated from the stems and leaves of O. borbonica. The known compounds (2-6) were isolated from the genus Ochrosia for the first time. The discovery of 1 is not only a further addition to the diverse and complex array of monoterpenoid indole alkaloids, but also the presence of 1-6 as characteristic markers may be helpful in chemotaxonomical classifications. The cytotoxicities against several human cancer cell lines of 1 and 2 were also investigated, and found to be quite potent.
Experimental

General experimental procedures:
Optical rotations were measured on a JASCO P-1020 digital polarimeter. UV spectra were recorded on a Beckman DU 640 spectrophotometer, IR spectra on a Nicolet 6700 spectrophotometer, and NMR spectra on a Bruker 400 MHz spectrometer using TMS as an internal standard. HRESIMS were measured on a Q-TOF Ultima Global GAA076 LC mass spectrometer. Semi-preparative HPLC was performed on an Agilent 1260 LC series with a DAD detector using an Agilent Eclipse XDB-C 18 column (250 × 9.4 mm, 5 µm). Silica gel (Qing Dao Hai Yang Chemical Group Co.; 200-300 mesh) and octadecylsilyl silica gel (YMC; 50 μm) were used for column chromatography (CC), and precoated silica gel plates (Yan Tai Zi Fu Chemical Group Co.; G60, F-254) for thin layer chromatography (TLC). 
Plant material:
Extraction and isolation:
The air-dried and powdered stems and branches of O. borbonica (15.8 kg) were extracted with 90% ethanol under reflux conditions, and the solvent was recycled in vacuo. The residue was dissolved in 0.37% HCl (pH 2-3) and the solution was subsequently basified using 10% ammonia to pH 9-10. The basic solution was partitioned with EtOAc, affording an EtOAc extract. The EtOAc fraction (168.3 g) was subjected to silica gel CC, eluted with CHCl 3 /CH 3 OH (99:1 to 50:50, v/v) yielding 5 fractions (Fr.1-Fr.5). Fraction 2 (23.6 g) was subjected to CC on silica gel using CHCl 3 /acetone (99:1 to 50:50, v/v) to afford 6 subfractions 2A-2F. Fraction 2B (3.8 g) was separated by silica gel CC eluted with light petroleum/EtOAc 70:30 to yield 3 (56.8 mg) and 6 (32.8 mg). Fraction 2C (3.2 g) was purified using Sephadex LH-20 cc eluted with CH 3 OH, then separated by semi-preparative HPLC (Agilent Eclipse XDB-C 18 column, i.d. 250 × 9.4 mm, 5 μm, 65% CH 3 OH, 2.5 mL/min, t R 13.7, 15.9, 19.8 and 26.2 min) to afford compounds 1 (8.9 mg), 2 (23.9 mg), 4 (65.8 mg) and 5 (128.6 mg). 
Ochroborbone (1)
Cytotoxicity bioassays:
The following human tumor cell lines were used: HL-60, SMMC-7721, A-549, MCF-7, and SW480. All cells were cultured in either RPMI-1640 or DMEM medium (Hyclone, Logan, UT, USA), supplemented with 10% fetal bovine serum (Hyclone) in 5% CO 2 at 37°C. The cytotoxicity assay was performed using the MTT method in 96-well microplates [11] . Briefly, adherent cells (100 μL) were seeded into each well of 96well cell culture plates and allowed to adhere for 12 h before drug addition, and suspended cells were seeded just before drug addition with an initial density of 1×10 5 cells/mL. Each tumor cell line was exposed to the tested compound at concentrations of 0.0625, 0.32, 1.6, 8, and 40 μM in triplicate for 48 h. Cisplatin (Sigma, St. Louis, MO, USA) was used as a positive control. After treatment, cell viability was measured and the cell growth curve plotted. IC 50 values were calculated by the Reed and Muench method [12] .
Supplementary material: NMR spectra ( 1 H and 13 C NMR, HSQC, HMBC, COSY, and ROESY) for compound 1 and NMR data for compounds 2-6. These materials are available free of charge via the Internet at http://www.naturalproduct.us/.
